Literature DB >> 3922830

Sulphonylurea and insulin: combined treatment in type 1 (insulin-dependent) diabetes.

B J Burke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922830     DOI: 10.1007/bf00273870

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  The mechanism of action of tolbutamide. Observations on the effects of sulfonylureas on peripheral metabolism in man.

Authors:  W J BUTTERFIELD; M M ARAB; A L BUCKLE; C CHLOUVERAKIS; T HANLEY; R F MAHLER; M J WHICHELOW
Journal:  Diabetes       Date:  1962       Impact factor: 9.461

2.  The acute effects of tolbutamide on forearm metabolism.

Authors:  B Zinman; R I Ogilvie
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

3.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

4.  Improved diabetic control in insulin-dependent diabetics treated with insulin and glibenclamide.

Authors:  B J Burke; M Hartog; M R Waterfield
Journal:  Acta Endocrinol (Copenh)       Date:  1984-09

5.  Stimulation of residual insulin secretion by glibenclamide in insulin dependent diabetics.

Authors:  B J Burke; R J Sherriff
Journal:  Acta Endocrinol (Copenh)       Date:  1980-11

6.  Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics.

Authors:  E A Ward; G M Ward; R C Turner
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-25

7.  Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.

Authors:  K P Ratzmann; B Schulz; P Heinke; W Besch
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics.

Authors:  G Grunberger; J Ryan; P Gorden
Journal:  Diabetes       Date:  1982-10       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.